Showing results (151-160 of 3,536) with videos related to
Sort By:
Pageof 354
Chemical Biology & Drug Design|July 20, 2013
Supervised evolution: research concerning the number of evolutions that occur under certain constraintsLorentz Jäntschi, Sorana D BolboacăChemical Biology & Drug Design|July 20, 2013
Combining structure-based pharmacophore and in silico approaches to discover novel selective serotonin reuptake inhibitorsZheng-Li Zhou, Hsuan-Liang Liu, Josephine W Wu, et al.Chemical Biology & Drug Design|July 2, 2013
Cantharidin-based small molecules as potential therapeutic agentsCarlos E Puerto Galvis, Leonor Y Vargas Méndez, Vladimir V KouznetsovChemical Biology & Drug Design|January 29, 2013
Sulfated small molecules targeting eBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNARaquel T Lima, Hugo Seca, Andreia Palmeira, et al.Chemical Biology & Drug Design|January 29, 2013
7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compoundsElaine S Coimbra, Luciana M R Antinarelli, Adilson D da Silva, et al.Chemical Biology & Drug Design|January 3, 2013
Optimization of antimalarial activity of synthetic prodiginines: QSAR, GUSAR, and CoMFA analysesVijay H Masand, Devidas T Mahajan, Komalsing N Patil, et al.Chemical Biology & Drug Design|January 3, 2013
Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agentsYan Wu, Liang-Peng Sun, Long-Xu Ma, et al.Chemical Biology & Drug Design|December 21, 2012
Beyond the hundred dollar genome--drug discovery futuresDavid L SelwoodChemical Biology & Drug Design|December 21, 2012
Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactionsLeah N Makley, Jason E GestwickiChemical Biology & Drug Design|December 21, 2012
The future of virtual compound screeningKathrin Heikamp, Jürgen BajorathPageof 354